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HUBUNGAN ANTARA POLIMORFIK GENETIK DAN TABIAT 
MEROKOK DI KALANGAN POPULASI MELAYU DI KELANTAN 
ABSTRAK 
 
Ketagihan merokok merupakan penyebab utama penyakit dan kematian di seluruh 
dunia. Bagaimanapun, disebalik risiko kesihatan yang diketahui, kelaziman merokok 
masih meningkat di seluruh dunia. Nikotina merupakan bahan utama yang 
menyebabkan ketagihan terhadap rokok. Faktor-faktor genetik memainkan peranan 
penting dalam setiap aspek ketagihan nikotin. Oleh itu, gen yang terlibat dalam 
farmakodinamik dan farmakokinetik nikotina merupakan kemungkinan penyebab 
terhadap ketagihan merokok. Empat gen telah dipilih di antara senarai gen yang 
mungkin terlibat dengan ketagihan merokok yang telah diterbitkan, iaitu reseptor 
asetilkolina nikotina (nAChR) rs2273502, rs2236196, pengangkut serotonin 
(5HTTLPR) dan reseptor serotonin (5HT2A). Hubungkait di antara gen-gen ini 
dengan tabiat merokok di kalangan populasi Melayu telah dikaji di dalam kajian ini. 
 
Kajian ini melibatkan seramai 248 orang lelaki Melayu yang merokok dan 248 orang 
lelaki Melayu yang tidak merokok. DNA diekstrak daripada leukosit. Hasil PCR bagi 
nAChR rs2273502 dan rs2236196 dan 5HT2A masing-masing dicerna oleh enzim 
penyekatan AfeI, Sau96I dan HpaII. Manakala gen 5HTTLPR dianalisis 
menggunakan teknik PCR sahaja dan hasilnya diklasifikasi sebagai pendek (S) atau 
panjang (L). 
 
Tiada mutasi bagi rs2273502 (genotip TT) dikesan dalam kumpulan bukan perokok 
manakala kekerapan bagi homozigos genotip CC dan heterozigos genotip CT dalam 
xiii 
 
kumpulan bukan perokok masing-masing ialah 75.8% dan 24.2%. Manakala bagi 
kumpulan perokok, kekerapannya masing-masing ialah 73.4%, 2.0% dan 24.6%. 
Tiada perbezaan yang signifikan dilihat bagi kekerapan genotip (χ2=5.106, p=0.078) 
dan alel (χ2=1.064, p=0.302) kedua-dua kumpulan. Taburan kekerapan bagi 
rs2236196 dalam kumpulan perokok ialah 80.6% untuk  homozigos genotip AA 
manakala bagi kumpulan bukan perokok ialah 77.0%. Tiada mutasi (genotip GG) 
dikesan dalam kedua-dua kumpulan. Genotip AG untuk kumpulan perokok ialah 
19.4% manakala bagi kumpulan bukan perokok ialah 23.0%. Tiada perbezaan yang 
signifikan dilihat dalam kekerapan genotip (χ2=0.979, p=0.323) dan alel (χ2=0.863, 
p=0.353) di antara kedua kumpulan yang dikaji. Kekerapan genotip bagi 5HT2A 
bagi kumpulan perokok pula ialah CC= 10.1%, TT= 46.8%  dan CT=43.1% 
manakala bagi kumpulan bukan perokok ialah  CC=8.1%, TT=46.4% dan 
CT=45.6%. Tiada perbezaan yang signifikan dilihat dalam kekerapan genotip 
(χ2=0.724, p=0.696) dan alel (χ2=0.075, p=0.784). Bagi 5HTTLPR pula, kekerapan 
genotip bagi SS, LL dan heterozigos SL masing-masing ialah 41.1%, 12.9% dan 
46.0% dalam kumpulan perokok. Manakala bagi kumpulan bukan perokok, 
kekerapan bagi  SS, LL dan heterozigos SL masing-masing ialah 39.1%, 11.3% dan 
49.6%. Tiada perbezaan yang signifikan bagi taburan kekerapan bagi genotip 
5HTTLPR (χ2 = 0.734, p=0.693) dan alel 5HTTLPR (χ2 = 0.004, p=0.947) bagi 
kedua-dua kumpulan yang dikaji. Kesimpulannya, tiada perbezaan signifikan antara 
reseptor asetilkolina nikotina (nAChR) rs2273502 dan rs2236196, pengangkut 
serotonin (5HTTLPR) dan reseptor serotonin (5HT2A) polimorfik dengan tabiat 
merokok di kalangan populasi Melayu di Kelantan. 
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RELATIONSHIP OF GENETIC POLYMORPHISMS WITH SMOKING 
BEHAVIOR IN THE MALAY POPULATION IN KELANTAN 
 
Smoking addiction is a leading cause of diseases and mortality worldwide. However 
despite the well-known associated risk to health, smoking prevalence is still 
increasing worldwide. Nicotine is the main addictive substance in cigarettes that is 
responsible for the development as well as maintenance of smoking addiction. 
Genetic variables appear to play a key role in every aspect of nicotine addiction. 
Therefore genes involved in pharmacodynamic and pharmacokinetic of nicotine are 
logical candidates for nicotine addiction. Among listed candidate genes published for 
their known association with nicotine, four of them were selected which were 
nicotinic acetylcholine receptor (nAChR) rs2273502 and rs2236196, serotonin 
transporter 5HTTLPR and serotonin receptor 5HT2A and their relationships with 
smoking behavior in the Malays were investigated in this thesis. 
The study involved 248 Malay male smokers and 248 Malay male nonsmokers. DNA 
was extracted from leucocytes. The PCR product of nAChR rs2273502 and 
rs2236196 and 5HT2A were digested with restriction enzymes AfeI, Sau96I and 
HpaII respectively. The 5HTTLPR genotypes were analyzed by using PCR method 
and the results were classified as short (S) alleles or long (L) alleles. 
No mutation of rs2273502 (TT genotype) was detected in the nonsmoker group 
whilst the frequencies of homozygous CC genotype and heterozygous CT in 
nonsmokers were 75.8% and 24.2%, respectively. While in smokers, the frequencies 
were 73.4%, 2.0% and 24.6%, respectively. No significant difference was observed 
in genotype (χ2=5.106, p=0.078) and allele (χ2=1.064, p=0.302) frequencies among 
both group. The frequency distribution for rs2236196 polymorphism in smoker 
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group was 80.6% for homozygous AA genotype while in nonsmoker 77.0%. No 
mutation (GG genotype) was detected in both groups. The AG genotype for smoker 
group was 19.4% while in nonsmoker group 23.0%. There was no significant 
difference observed in the genotype (χ2=0.979, p=0.323) and allele frequencies 
(χ2=0.863, p=0.353) between both groups. The genotype frequencies for 5HT2A 
polymorphism in smokers are CC= 10.1%, TT= 46.8%  and CT=43.1%. While for 
nonsmokers are CC=8.1%, TT=46.4% and CT=45.6%. There was no significant 
difference observed in the genotype 5HT2A (χ2=0.724, p=0.696) and allele 
frequencies (χ2=0.075, p=0.784). On the other hand, for 5HTTLPR polymorphism, 
the frequencies of variant alleles S, L and heterozygous SL in nonsmokers were 
39.1%, 11.3% and 49.6%, respectively. While in smokers, the frequencies of variant 
alleles S, L and heterozygous SL were 41.1%, 12.9% and 46.0%, respectively. No 
significant difference in the frequency distribution of alleles was found between 
smokers and nonsmokers of genotype 5HTTLPR (χ2 = 0.734, p=0.693) and allele 
frequencies (χ2 = 0.004, p=0.947) for both group studied.  
In conclusion, the nicotinic acetylcholine receptor (nAChR) rs2273502 and 
rs2236196, serotonin transporter (5HTTLPR) and serotonin receptor (5HT2A) 
polymorphisms were not found to be associated with the smoking behavior in Malay 
male subjects in Kelantan. 
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CHAPTER 1 
 
LITERATURE REVIEW AND INTRODUCTION 
 
1.1 Smoking 
Tobacco consumption is well known as a leading cause of preventable morbidity and 
mortality worldwide, hence is a critically public health concern. It is a major 
contributor to many diseases such as stroke, heart disease, chronic obstructive 
pulmonary disease (COPD), periodontal disease, peripheral vascular disease, 
pneumonia, lung and oral cancer (Lung et al., 2005)  
 
The tobacco epidemic kills 5.4 million people in average per year from lung cancer, 
heart disease, and other illnesses. If this smoking trend continues, there will be more 
than 8 million deaths every year, with more than 80% of tobacco-related deaths in 
developing countries by 2030 (Mathers and Loncar, 2006). As a result, tobacco will 
kill a billion people due to smoking related disease during this century.  
 
In Malaysia, smoking-related diseases have been the primary cause of mortality for 
the past three decades. It is estimated that one-fifth of disability adjusted life years 
(DALYs) and one-third of years of life lost (YLL) for Malaysians were due to 
smoking-related diseases (Yusoff et al., 2005) 
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1.1.1 Smoking prevalence in Malaysia 
 
In 2012, The Global Adult Tobacco Survey Malaysia (GATS Malaysia) reported 
23.1% or 4.75 million Malaysian adults aged 15 years or older were current smokers 
of tobacco with 43.9% (4.64 million) of men and 1.0% (0.10 million) of women. On 
average, a daily Malaysian adult smoker smoked 14 cigarettes per day in 2011. More 
than half (51.8%) of those aged 20-34 years who had ever smoked on a daily basis 
had started smoking daily before the age of 18. Among the three main racial/ethnic 
groups in Malaysia, 22.3% of Malays, 17.2% of Indians, and 14.2% of Chinese were 
daily smokers. The proportions of nonsmokers were 84.6% of Chinese, 80.4% of 
Indians and 75.4% of Malays. The survey shows significantly higher proportion of 
Muslims (23.2%) than non-Muslims (16.2%) smoked a tobacco product daily, while 
the percentage of nonsmokers was significantly higher for non-Muslims (81.7%) 
than Muslims (74.4%) (WHO, 2012). 
 
According to the Ministry of Health Malaysia (MOH), tobacco use in Malaysia 
accounts for 35% of in-hospital deaths, principally from cancer, heart disease and 
stroke. More than 10 000 Malaysians die from smoking-related illnesses each year 
(WHO, 2012). Statistics from the Ministry of Health Malaysia in 2006 revealed that 
diseases related to smoking remained the top causes of death in MOH hospitals, 
accounting for more than 15% of hospitalizations and 35% of in-hospital deaths. 
Heart diseases and diseases of pulmonary circulation ranked first, accounting for 
15.7% of these deaths, followed by malignant neoplasms, 10.6%, and 
cerebrovascular diseases, 8.5% (MOH, 2006). 
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1.1.2 Tobacco 
 
Tobacco is an agricultural product and an end product of the fresh tobacco leaf. It is 
from the genus of Nicotiana of the Solanaceae family plants. Dried leaves are used to 
produce tobacco products. There are several types of tobacco products such as 
cigarette, chewing tobacco and cigarette pipe tobacco (Giuseppe et al., 2013). 
Tobacco for cigarettes is generally derived from two varieties of plants: 
1) Virginia, a yellowish “bright” leaf contain about 3% of nicotine 
2) Burley, with higher quantity of nicotine (Giuseppe et al., 2013) 
Tobacco use is a repetitive and compulsive behavior characteristic of drug addiction. 
 
1.1.3 Nicotine and nicotine addiction 
 
Several compounds of cigarettes are toxic, but they are not addictive. The addiction 
is caused by nicotine, which is the major tobacco alkaloid. Nicotine is an N-
alkylpyrrolidine that consists of N-methylpyrrolidine bearing a pyridin-3-yl 
substituent at position 2 (Figure 1.1).  
 
It is commonly used as a psychoactive drug that is orally self-administered via the 
chewing or combustion of tobacco products, the latter typically via cigarette use. 
According to Henningfield et al., (1985), cigarettes represent “the most toxic and 
addictive form of nicotine delivery” 
 
Nicotine is primarily responsible for the development and maintenance of tobacco 
dependence (Henningfield et al., 1985). Understanding the neural substrate of 
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nicotine addiction is the first step to develop medication for smoking cessation 
therapy. According to Palca (1988), the behavioral and pharmacological 
characteristic for nicotine addiction are similar to cocaine and heroin addiction. 
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Figure 1.1 Structure of nicotine molecule 
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1.1.4 The biology of nicotine addiction 
 
Nicotine acts on nicotinic cholinergic receptors, then triggering the release of 
neurotransmitters that produce psychoactive effects that are rewarding. After 
repeated exposure, tolerance will develop to the effects of nicotine, thus reducing its 
primary reinforcing effects and inducing physical dependence such as withdrawal 
symptoms in the absence of nicotine. According to Benowitz (2010), smoking 
behavior is influenced by pharmacologic feedback as well as environmental factors. 
Examples of environmental factors are smoking cues, friends who smoke, stress, and 
product advertising. Levels of nicotine in the body in relation to a particular level of 
nicotine intake from smoking are modulated by the rate of nicotine metabolism. 
Other factors that influence smoking behavior include age, sex, genetics, mental 
illness, and substance abuse (Figure 1.2)  
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Figure 1.2 The Biology of Nicotine Addiction. (Adapted from Benowitz, 2010) 
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1.1.5 Metabolism of nicotine in the body 
 
The effects of nicotine are strongly influenced by its complex metabolism. Nicotine 
influences mood, cognition, and body function by binding to and activating nicotinic 
acetylcholine receptor (nAChR). This receptor is located on neurons in the central 
nervous system (CNS). During activation by either nicotine or the endogenous 
neurotransmitter acetylcholine, the nAChR opens a channel that allows ions to pass 
through the neuron‟s membrane from the exterior to the interior of the cell. This will 
trigger changes that activate the cell (D'Souza and Markou, 2011). This binding is at 
the base of the neurobiology of nicotine addiction and is the major obstruction for 
smokers who try to quit (Benowitz, 2010) 
 
When tobacco is smoked, the nicotine in the smoke enters the blood vessels in the 
lungs and reaches the brain within 10 sec of the first puff (Benowitz et al., 2009) 
Consequently, nicotine binds to receptors located on the cell bodies of neurons in the 
vetral tegmental area (VTA) and the terminals of these neurons. Normally, the 
neurotransmitter acetylcholine bind to these receptors.  As nicotine has a very 
similarly structured to acetylcholine, it is able to bind to the acetylcholine receptor. 
Nicotine has specific acetylcholine receptors (nAChRs) in the brain and other organs. 
The stimulation of presynaptic acetylcholine receptors increases the release of 
acetylcholine as well as the metabolism (Pidoplichko et al., 2004) 
 
Similarly to other drugs of abuse, nicotine triggers the dopamine reward system and 
increases the extracellular level of dopamine in nucleus accumbens (NAc). NAc has 
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a fundamental role for the reinforcing behavior, stimulant, and dependence properties 
of nicotine (Pidoplichko et al., 2004). 
 
According to Quaak et al., (2009), smokers with a reduced nicotine metabolism and 
increased dopamine levels are less seems to have addicted to smoking, smoke less, 
and have a higher chance to quit. On the other hand, smokers with an increased 
nicotine metabolism and reduced dopamine levels, seem to be more addicted. They 
have a higher chance to become a smoker, start smoking at a lower age, smoke more 
cigarettes, and also undergo fewer and less successful smoking cessation attempts. 
 
 
1.2 Genetic polymorphism and smoking behavior 
 
 
Genetic polymorphism is define as mutant or variant genes that exist at a frequency 
of more than 1% in the normal population (Meyer, 2000). A major difference 
between genetic and environmental variation is that an inherited mutation or trait is 
present throughout life has to be tested for only once in a lifetime, whereas 
environmental effects are continually changing.  
 
Genetic polymorphisms explain why a small proportion of the population may be at 
higher risk of drug inefficacy or toxicity. The gene polymorphism‟s study has given 
rise to the field of pharmacogenetics. Genetic polymorphisms are a source of 
variation of drug response in the human body. In relation to cigarette smoking, most 
interest has focused on the involvement of pharmacokinetic factors and, in particular, 
nicotine metabolism. Nowadays, there is increasing recognition that genetic variation 
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in nicotine targets (pharmacodynamic factors) might also influence to smoking 
behavior. 
 
1.2.1 Single Nucleotide Polymorphism (SNP) 
 
Single nucleotide polymorphisms (SNPs) are differences in single bases of DNA. 
SNPs occurs in about 90% of sequence variants in humans throughout the human 
genome. The International SNP Map Working Group has published a map of 1.42 
million SNPs throughout the genome, occurring at an average density of one SNP 
every 1.9 kilobases (The International SNP Map Working Group, 2001) 
 
1.2.2   Candidate genetic polymorphism and smoking behavior 
 
Candidate gene studies focus on genes that have been selected either because of their 
location within an identified linkage region (positional candidate genes) or because 
of their hypothetical aetiological role in disease (functional candidate genes). 
Functional candidate gene selection process is made with a careful investigation of 
the earlier published studies and by evaluating known hypothesised biological 
pathways involved in the studied phenotype.  
 
Several genes have been shown to be associated with tobacco smoking. To date, 
candidate gene association studies have focused on genes in a few candidate 
pathways. Variants in two broad classes of candidate genes have been suggested to 
contribute to smoking behavior:  
1) Genes that may influence the response to nicotine (e.g. nicotine metabolism, 
nicotinic receptors)  
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2) Genes that may predispose to addictive behavior due to their effects on key 
neurotransmitter pathways (e.g. dopamine, serotonin, opioid) (Quaak et al., 2009). 
 
1.3 Specific candidate genes in smoking behavior 
 
A „reward deficiency syndrome‟ has been recognized as of the one reasons to be the 
role of diverse neurotransmitters in nicotine dependency (Blum et al., 2000). 
Therefore, many studies have evaluated genes in opioid (Lerman et al., 2004), 
serotonin (Lerman et al., 2000; Iordanidou et al., 2009; Iordanidou et al., 2010), 
dopamine (Shields et al., 1998; Blum et al., 2000), drug metabolizing enzymes 
(Malaiyandi et al., 2005; Benowitz et al., 2006), nicotinic and muscarinic cholinergic 
receptor pathways (Li et al., 2005). Some candidate genes involved in dopaminergic 
function are area of research interest involving a wide range of addictive and other 
behavioral disorders. Other genes, including some of the cytochrome P450 family as 
well as the nicotinic acetylcholine receptor are also considered reasonable candidates 
to influence smoking behavior. This is because they are involved in neural activity or 
metabolism of nicotine. 
 
Polymorphisms of a variety of genes involved in serotonergic neurotransmission 
have been identified. The serotoninergic system may be involved in smoking 
behavior because nicotine increases brain serotonin secretion, nicotine withdrawal 
decreases serotonin levels, and a selective serotonin reuptake inhibitor antagonizes 
the response to nicotine (Ishikawa et al., 1999) 
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It has been suggested that nicotine-induced release of dopamine drives tobacco 
usage, while receptor inactivation due to chronic nicotine use may play a role in the 
processes of tolerance and withdrawal (Dani and De Biasi, 2001). Genetic 
differences in nicotinic receptor activity or nicotine metabolism might reasonably be 
hypothesized to play a role in smoking addiction. Nicotinic receptors are present in 
the brain, autonomic ganglia, and the neuromuscular junction. Neuronal nicotinic 
acetylcholine receptors are believed to be most relevant to nicotine addiction.  
 
Therefore, the polymorphism on nicotinic acetylcholine receptors genes and 
serotonin genes represent logical candidates for an association study with smoking 
behavior. 
 
1.3.1 Nicotinic Acetylcholine Receptor (nAChR) 
The behavioral and physiological effects of nicotine are mediated largely by neuronal 
nicotinic acetylcholine receptors (nAChRs). Nicotine functions by binding to 
nAChRs, which, in turn, modulate the release of dopamine in the mesolimbic system 
(Pidoplichko et al., 1997).  
 
 
1.3.1.1 Structural characteristic and function of nAChR 
The nicotinic acetylcholine receptors (nAChRs) belong to the superfamily of the 
Cys-loop ligand-gated ion channels (LGICs), which also include the GABA, glycine, 
and 5-HT3 receptors. They are formed by the assembly of five transmembrane 
subunits selected from a pool of 17 homologous polypeptides (α1–10, β1–4, γ, d, and 
e). There are many nAChR subtypes, each consisting of a specific combination of 
subunits, which mediate diverse physiological functions. These receptors are widely 
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expressed in the central nervous system, and, in the periphery, they mediate synaptic 
transmission at neuromuscular junctions and ganglia (Lee et al., 2011). Among them, 
α 4 and β 2 subunits are the most widely and concurrently expressed high-affinity 
nAChR subunits in the brain  and are both upregulated under chronic nicotine 
exposure (Whiteaker et al., 1998). The gene that encodes the human nAChR α 4 
subunit  (locus ID 1137) was mapped by FISH to 20q13.2-13.3 (Steinlein et al., 
1994). The gene is ~17 kb in size and comprises six exons (Steinlein et al., 1996). 
 
1.3.1.2 Polymorphism in CHRNA4 and association with smoking behavior 
 
CHRNA4, the gene that encodes the nicotinic acetylcholine receptor α4 subunit, is a 
potential candidate gene for nicotine dependence. However, studies of the 
association of CHNRA4 with smoking behavior have shown inconsistent results. 
CHRNA4 is highly expressed in the central nervous system, and its protein product 
is part of high affinity receptors (α4β2) for nicotine. It plays a major role in 
tolerance, reward, and the modulation of mesolimbic dopamine function, all of which 
are critical to the development of nicotine dependence (Tapper et al., 2004).  
Although some genetic association studies support the role of CHRNA4 in smoking-
related behaviors (Feng et al., 2004; Li et al., 2005; Hutchison et al., 2007; Breitling 
et al., 2009), there have been conflicting results (Ehringer et al., 2007; Etter et al., 
2009). 
 
1.3.1.2.1 rs2273502  
Mutation in rs2273502 involved C        T transition located in exon 5 in CHRNA4. 
rs2273502 polymoprhism has been reported has association with attention deficit/ 
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hyperactivity disorder ADHD (Weidong et al., 2009). Emerging research shows a 
higher incidence of smoking in individuals with ADHD compared with the general 
population. Data from a number of longitudinal studies have shown clearly that 
individuals with ADHD are at increased risk for cigarette smoking compared to their 
peers who do not have ADHD (Lambert and Hartsough, 1998). ADHD symptoms 
have also been shown to influence the route of smoking behavior from initial use to 
regular use and dependence. One study found that a lifetime diagnosis of ADHD was 
a significant predictor of progression from initiation of smoking to daily use (Rohde 
et al., 2004). Study done by Spruel et al., (2012) shows there was association of 
rs2273502 with smoking abstinence.   
1.3.1.2.1 rs2236196 
Polymorphism in of CHRNA4 rs2236196 located in the 3‟ UTR region (A        G 
transition).  Several analyses have been carried out on CHRNA4 rs2236196. 
According to Hutchison et al., (2007), there was a significant association with 
abstinence at 6 months, while in another, the association was seen with nicotine 
dependence in both European Americans and African Americans (Li et al., 2005). 
An association study in 5,500 Germans showed that rs2236196 was significantly 
associated with Fagerstrom Test Nicotine Dependence (FTND) and the „„G‟‟ allele 
was associated with a higher risk of nicotine addiction and higher odds of being a 
smoker (Breitling et al., 2009). The accumulating evidence from genetic association 
studies and the additional findings on clinical effects (Hutchison et al., 2007) suggest 
that rs2236196 could be one of the most promising risk variants for smoking related 
behaviors. 
 
15 
 
1.3.2 Serotonin transporter 
 
1.3.2.1 Structural characteristic and function of serotonin transporter 
Serotonin transporter 5-HTT is a member of the sodium and chloride dependent 
neurotransmitter transporter (SLC6) family (Saier, 2000). It is a 630 amino acid 
protein and it has 12 transmembrane domains. Its C and N terminal resions lie in the 
cytoplasm (Rudnick and Clark, 1993). They are responsible for regulating the 
magnitude and duration of serotonergic neurotransmission. 
 
This protein selectively transports serotonin together with Na
+ 
 ans Cl
-
 into cells and 
in the same reaction transports K
+
 out of the cell modulating serotonergic signaling 
and neurotransmission (Blakely et al., 1994). Serotonin transporter, 5HTT, controls 
the duration and concentration of serotonin neurotransmission in synaptic cleft (Uhl 
and Johnson, 1994). It is encoded by a single gene (SLC6A4) located on the longer 
arm of the seventh chromosome (17q12) (Ramamoorthy et al., 1993). The 5HTT 
gene has been linked to psychological traits such as anxiety-related personality traits 
(Lesch et al., 1996) and depression (Collier et al., 1996; Ogilvie et al., 1996), both 
are related with nicotine dependence (Lerman et al., 1996; Audrain et al., 1998) .  
 
1.3.2.2 Polymorphism in serotonin transporter and association with smoking  
A 44 bp insertion or deletion polymorphism, 5HTTLPR, was identified within this 
gene with two allelic variants, the long (L) and the short (S) allele which altered the 
transcriptional efficiency of the 5HTT gene (Heils et al., 1996). S allele was 
associated with reduced serotonin uptake leading to hypothesis that individual with S 
allele is not likely to be a smoker (Heils et al., 1996). This hypothesis is supported by 
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two studies in Japanese and Chinese population that found individuals with 
homozygous S genotype were less likely to initiate smoking behavior and could 
easily stop smoking than others (Ishikawa et al., 1999; Chu et al., 2009) . However 
the hypothesized role of S allele in smoking behavior has yet not been confirmed as 
other studies that attempt to replicate these findings have obtained contradictory 
results (Trummer et al., 2006; Sieminska et al., 2008b; Iordanidou et al., 2009; 
Rasmussen et al., 2009) . 
 
1.3.3 Serotonin receptor 
 
1.3.3.1 Structural characteristic and function of serotonin receptor 
Serotonin, 5-hydroxytryptamine (5-HT), is a neurotransmitter synthesized by 
tryptophan hydroxylas with the decarboxylation of the essential amino acid 
tryptophan. It is present in the central nervous system. About 90% of 5-HT is 
wrapped by the chromatophil cells of the alimentary canal, 9% exists in blood 
platelets and 1% exist in the brain. Central 5-HT is synthesized in the raphe nucleus 
cells. It is transported to the nerve endings, where it is stored in granules. When a 
stimulant impulse connects with the nerve endings of the raphe nucleus origin, 
depolarization occurs and 5-HT is emitted to the synaptic cleft, where it combines 
with the serotoin receptor (5-HTR) of the postsynapse. 5-HT will trigger a strong 
vital reacton by the receptor that combines through the signal transduction system in 
the cells (Terayama et al., 2004). 
 
5-HTR is related to affectivity, regulation and pharmacologic effects of 
antidepressant, anti-anxiety and anti-psycotic medications. It is thought to be 
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associated with various psychiatric disorders (including schizophrenia, eating 
disorders, alcoholism and anxiety disorders) (Abbas and Roth, 2008).  
 
1.3.3.2 Polymorphism in serotonin receptor and association with smoking  
The serotonin receptor is classified into seven groups (5HT1-7). Group 2 is divided 
into three subtypes (A, B, and C). The 5HT2A gene is located on chromosome 
13q14–q21 (Peroutka, 1998). The 5HT2A gene has been associated with emotional 
disorders and alcohol dependence, which are related to smoking behavior (Polina et 
al., 2009). One of the polymorphisms that has been described in this receptor is 
T102C, which involves the replacement of a cytosine with a thymine (Peroutka, 
1998). This polymorphism has been associated with smoking maintenance but is less 
likely to be involved in the initiation of smoking behavior (do Prado-Lima et al., 
2004). A study conducted in a Brazilian population found that individuals with the 
CC genotype are more likely to be current smokers than individuals with other 
genotypes. Interestingly, the opposite finding was obtained in Caucasian Australians 
that suggest the occurrence of the TT genotype was associated with current smokers 
(White et al., 2010). However, this finding was not replicated in several other studies 
in other populations (Terayama et al., 2004; Huang et al., 2005; Suriyaprom et al., 
2012) 
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1.4 Study objectives 
 
To date, studies examining the association gene polymorphism with smoking 
behavior have yield contradictory result among different population. It is important 
to be able to test the linkage of candidate genes in several populations with different 
ethnicity in order to confirm and solidify the actual gene that affects smoking 
behavior. No investigation on the association of these gene polymorphisms and 
smoking has been carried out so far in Malay population. Therefore, the objectives of 
this study are: 
 
1) To develop and optimize polymerase chain reaction method – restriction 
fragment length polymorphism (PCR-RFLP) techniques and use these 
methods to study nicotinic acetylcholine receptors (nAChRs) rs2273502 
and rs2236196, serotonin receptor (5HT2A) and transporter (5HTTLPR) 
genes polymorphisms among Malay populations 
 
2) To estimate the prevalence of nicotinic acetylcholine receptors (nAChRs) 
rs2273502 and rs2236196, serotonin receptor (5HT2A) and transporter 
(5HTTLPR) in the Malay population in Kelantan 
 
3) To determine the association between nicotinic acetylcholine receptors 
(nAChRs) rs2273502 and rs2236196, serotonin receptor (5HT2A) and 
transporter (5HTTLPR) genes polymorphisms with smoking behavior 
among Malay smokers and nonsmokers. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1 Clinical Study 
2.1.1 Ethical Approval 
The study protocol was approved by the Research and Ethics Committee of School 
of Medical Sciences, Universiti Sains Malaysia in the year 2011 
[USMKK/PPP/JEPeM [233.3.(05)]. The ethical approval letter was attached in the 
Appendix A.  
 
2.1.2 Materials and instruments 
The materials used for the clinical study are as listed in Table 2.1 
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Table 2.1 List of commercial kits and consumables used in the clinical studies. 
Material Model and Supplier 
K2EDTA tube Vacutest, Arzergrande, Italy 
Alcohol swab 70% isopropyl alcohol JR, Selangor, Malaysia 
Syringe (5 ml) Becton Dickinson, Singapore 
21G Needle Teromo, Tokyo, Japan 
Blood Pressure Monitor Omron, Kyoto, Japan 
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2.1.3 Sample size calculation 
Sample size for this study was calculated according to a case-control study done by 
Polina et al., (2009). They found that the prevalence of 5HT2A variant of wild-type 
among European who lived in Brazil in nonsmokers group was 36% (p1). For 
smokers group, it is estimated that prevalence of this gene is 24% (p2) after 
reviewing other literatures. 
By using a two proportions (Independent Observations) formula with 95% 
confidence interval, a minimum sample size (n) of 248 subjects was obtained.  
Calculation of sample size 
                    n =  p1 (1- p1) + p2(1- p2)   (z + z)
2
  
                                     (p1- p2)
2
    
                       =   (0.36)(1-0.36) + (0.24)(1-0.24)    (1.96 +0.84)
 2
  
                                           (0.36-0.24)
 2
  
                       = 224.74 x 10% dropout  
                       = 248 
Where,  n = sample size  
             z = 1.96 for  set at 0.05  
             z = 0.84 for  set at 0.20   
                    (power 80%)  
             p1 = proportion 1  
             p2 = proportion 2 
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2.1.4 Subject recruitment 
The subjects were selected from healthy Malay adult volunteers aged between 18 and 
50. They were categorized as smokers group and nonsmokers group (control) based 
on their smoking status. The inclusion and exclusion criteria of the subjects are 
described in Table 2.2. 
All the subjects involved in this study were given a detailed description about the 
study procedure; the objectives, benefits as well as risk before they agreed and 
signed written the informed consent (Appendix B). Information obtained from the 
subjects was kept as confidential and each subject was given a copy of information 
sheet. 
The recruitment of the subjects was done at  Hospital Universiti Sains Malaysia 
(HUSM), Institut Perguruan (IPG) Pengkalan Chepa and several places around the 
state of Kelantan, based on the inclusion and exclusion criteria.  
 
Height of the subjects was taken in cm and weight measurements were taken in kg. 
Body mass index (BMI) was then calculated as weight (kg) divided by height 
squared (m
2). Blood pressure was measured on the subject‟s right arm after the 
subjects being rested in a sitting position for 5 min, using an automated blood 
pressure monitor. The blood pressure was taken twice at 2 min interval. Mean 
systolic and diastolic blood pressure was obtained by calculating the averages of 
systolic and diastolic blood pressure. 
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Table 2.2 Inclusion and exclusion criteria of the subjects 
      Inclusion criteria       Exclusion criteria 
 Malay (3 generations)  Non Malay 
 Male  Female 
 Healthy volunteers aged between 
18-50 
 Aged less than 18, and more 
than 50 
 Being a smoker during study 
period (Smokers group) 
 Ex-smoker 
 Never (Nonsmokers group)  Under smoking cessation 
treatment 
  History of mental disorder 
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2.1.4.1 Data collections 
All subjects were given data collection sheets to record the subject‟s information. 
The data collection sheets were given based on the smoking status group (Appendix 
C). Smoking history and family background of the subjects were obtained. 
 
2.1.4.2 Fagerstrom Test 
The Fagerstrom Test for Nicotine Dependence (FTND) is a widely used six-item 
questionnaire, which was used as a measure of physical dependence on nicotine. The 
higher the Fagerstrom score, the more intense is the individual‟s physical 
dependence on nicotine. FTND was given to subject who has been identified as 
smoker (Appendix D). The three yes/no items are scored 0 (no) and 1 (yes). The 
three multiple-choice items are scored from 0 to 3. The items are summed to yield a 
total score of 0-10. The score of the subject was calculated and the subjects were 
classified into five level categorization which were very low nicotine dependence (0-
2), low nicotine dependence (3-4), moderate nicotine dependence (5), high nicotine 
dependence (6-7) and very high nicotine dependence (8-10) according to the score 
(Table 2.3) 
 
 
 
 
 
